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The presence of systemic inflammation before surgery, as evidenced by the glasgow prognostic score (mGPS), predicts poor long-
term survival in colorectal cancer. The aim was to examine the relationship between the preoperative mGPS and the development of
postoperative complications in patients undergoing potentially curative resection for colorectal cancer. Patients (n¼455) who
underwent potentially curative resections between 2003 and 2007 were assessed consecutively, and details were recorded in a
database. The majority of patients presented for elective surgery (85%) were over the age of 65 years (70%), were male (58%), were
deprived (53%), and had TNM stage I/II disease (61%), had preoperative haemoglobin (56%), white cell count (87%) and mGPS 0
(58%) in the normal range. After surgery, 86 (19%) patients developed a postoperative complication; 70 (81%) of which were
infectious complications. On multivariate analysis, peritoneal soiling (Po0.01), elevated preoperative white cell count (Po0.05) and
mGPS (Po0.01) were independently associated with increased risk of developing a postoperative infection. In elective patients, only
the mGPS (OR¼1.75, 95% CI¼1.17–2.63, P¼0.007) was significantly associated with increased risk of developing a postoperative
infection. Preoperative elevated mGPS predicts increased postoperative infectious complications in patients undergoing potentially
curative resection for colorectal cancer.
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Colorectal cancer remains the second most common cause of
cancer death in Western Europe (Cancer Research UK, 2004).
Despite advances in surgical techniques, perioperative care and
adjuvant chemoradiotherapy, overall survival remains poor with
only 50% patients surviving 5 years after potentially curative
resection (McArdle and Hole, 2002).
Although tumour stage has been the main basis for predicting
long-term survival in patients undergoing surgery for cancer, it is
now recognised that postoperative complications contribute to
poor cancer-specific survival (Rizk et al, 2004; Khuri et al, 2005;
McArdle et al, 2005; Law et al, 2007). In particular, McArdle et al
(2005) reported that in a prospective cohort of 2235 patients
undergoing potentially curative resection for colorectal cancer, the
postoperative complication of anastomotic leakage was associated
with poorer cancer-specific survival, independent of Dukes stage.
Law et al (2007) reported similar results in 1657 patients who
underwent curative resection for colorectal cancer.
The basis of this observation is not clear. It has been postulated
that the presence of an enhanced systemic inflammatory response
may be responsible (McArdle et al, 2005), as the systemic
inflammatory response, as evidenced by an elevated C-reactive
protein concentration, has been shown to be associated with poor
cancer-specific survival, independent of tumour stage (Nielsen
et al, 2000; McMillan et al, 2003; Crozier et al, 2006). Studies have
shown that elevated C-reactive protein concentrations in the
postoperative period may predict an increased chance of post-
operative infection (Welsch et al, 2007) and anastomotic leakage
(Matthiessen et al, 2008). An initial appraisal might suggest that
early postoperative infection initially declares itself as a rise in
C-reactive protein before overt clinical infection develops, and
this infection causes decreased long-term survival. However, it has
been reported that the preoperative, but not the immediate
postoperative, elevated C-reactive protein concentrations are
associated with cancer-specific survival (Crozier et al, 2007).
With respect to the measurement of the systemic inflammatory
response the combination of C-reactive protein and albumin
(glasgow prognostic score (mGPS)) has been shown to improve
the prediction of cancer-specific survival in a variety of common
solid tumours (McMillan, 2008) including primary operable
colorectal cancer (McMillan et al, 2007; Ishizuka et al, 2007). To
our knowledge, the relationship between the preoperative systemic
inflammatory response and postoperative complications has not
been examined previously.
The hypothesis underlying this study was that a preoperative
systemic inflammatory response, as evidenced by the mGPS, may
be an underlying host characteristic that predisposes to post-
operative infection in patients undergoing potentially curative
resection for colorectal cancer.
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Patients
Patients with histologically proven colorectal cancer who, on the
basis of laparotomy findings and/or preoperative abdominal
computed tomography, were considered to have undergone a
potentially curative resection and had routine laboratory measure-
ment of white cell counts, albumin and C-reactive protein, between
January 2003 and October 2007, at Glasgow Royal Infirmary,
were prospectively included in the study. The antibiotic regimen
was based on 1g second-generation cephalosporin and 500mg
metronidazole at induction of general anaesthesia. No other
antibiotics were normally given. Three consultant surgeons
(Anderson, Horgan and McKee) performed the majority of the
operations (79%). The surgical approach was open in all cases.
Patients were assessed consecutively and their details were
recorded in our colorectal cancer database. The tumours were
staged according to the TNM criteria (American Joint Committee
on Cancer Colon and rectum, 2002). Patients who had preoperative
clinical evidence of infection or other inflammatory conditions
were excluded from the study. A total of 23 patients were excluded
on the basis of these criteria.
The extent of deprivation was defined using the Carstairs
deprivation index (Carstairs and Morris, 1991). This is an area-
based measure derived from the 2001 census, using the postcode
of residence at diagnosis, which divides the score into a seven-
point index. For illustrative purposes, these results are presented
by amalgamating the seven categories into three groups: affluent
(categories 1 and 2), intermediate (categories 3–5) and deprived
(categories 6 and 7). The Carstairs deprivation index has been
extensively utilised in cancer patients, and is particularly appropriate
for use in the central belt of Scotland (Hole and McArdle, 2002).
Patients were assessed for the following complications: infec-
tious (wound infection, intra-abdominal abscess, anastomotic leak,
pneumonia and septicaemia) and noninfectious (cardiac events
encompassing acute coronary syndrome and acute myocardial
infarction and pulmonary embolism). The criteria used to define
infectious complications were the same as that described
previously (Ytting et al, 2005). (1) Wound infection was defined
as the presence of pus, either discharged spontaneously or
requiring drainage. Wound infection included a subgroup of
patients with perineal infection, following abdominoperineal
resection of the rectum. (2) Intra-abdominal abscess was verified
by either surgical drainage or by ultrasonographically guided
aspiration of pus. (3) Anastomotic leakage was defined as
radiologically verified fistula to bowel anastomosis or diagnosed
by relaparatomy. (4) Pneumonia was defined by fever above 38.51C
and a positive X-ray, and requirement of antibiotic treatment.
(5) Septicaemia was defined by clinical symptoms combined with a
positive blood culture.
Non-symptomatic or minor urinary tract infection was not
recorded, and therefore only included if complicated by septicaemia.
The study was approved by the Research Ethics Committee,
Royal Infirmary, Glasgow.
Blood parameters
Routine preoperative laboratory measurements of white cell count,
albumin and C-reactive protein concentration were carried out.
The coefficient of variation for these methods, over the range of
measurement, was o10% as established by routine quality control
procedures.
The mGPS was constructed as described previously (McMillan
et al, 2007). Briefly, a normal albumin (435gl
 1) and normal
C-reactive protein (o10mgl
 1) scores 0, with an elevated C-reactive
protein scoring 1 and an elevated C-reactive protein together with a
low albumin scoring 2.
Statistics
Data are presented as median (range). Grouping of the variables was
carried out using standard thresholds. Comparisons between groups
of patients were carried out using the Mantel–Haenszel (w
2)t e s tf o r
trend as appropriate. Logistic regression analysis was used to
examine the effect of variables on the development of postoperative
infection. Analysis was performed using SPSS software (SPSS for
Windows Version 15.0, SPSS Inc., Chicago, IL, USA).
RESULTS
The relationship between the preoperative systemic inflammatory
response (mGPS) and clinicopathological characteristics in
Table 1 The relationship between the preoperative systemic inflamma-
tory response (mGPS) and clinicopathological characteristics in patients
undergoing potentially curative surgery for colorectal cancer (n¼455)
mGPS 0 mGPS 1 mGPS 2
n¼259 (%) n¼130 (%) n¼66 (%) P-value
Age
o65 years 88 (34) 28 (28) 22 (33)
65–74 years 88 (34) 46 (35) 18 (27)
X75 years 83 (32) 48 (37) 26 (40) 0.283
Sex
Female 98 (38) 62 (48) 30 (46)
Male 161 (62) 68 (52) 36 (54) 0.102
Deprivation
Affluent (1, 2) 15 (6) 1 (1) 2 (3)
Intermediate (3, 4, 5) 118 (46) 53 (40) 24 (36)
Deprived (6, 7) 126 (48) 76 (59) 40 (61) 0.014
Presentation
Elective 245 (95) 100 (77) 40 (61)
Emergency 14 (5) 30 (23) 26 (39) o0.001
Peritoneal soiling
None or serous fluid 256 (98%) 126 (97%) 61 (92%)
Local pus 2 (1%) 4 (3%) 4 (6%)
Free pus or faeces 1 (1%) 0 (0%) 1 (2%) 0.010
Tumour site
Colon 128 (49) 93 (72) 54 (82)
Rectum 131 (51) 37 (28) 12 (18) o0.001
Tumour
T1 24 (9) 3 (2) 0 (0)
T2 48 (19) 9 (7) 4 (6)
T3 128 (49) 69 (53) 33 (50)
T4 59 (23) 49 (38) 29 (44) o0.001
Nodal involvement
N0 164 (63) 75 (58) 37 (56)
N1 72 (28) 34 (26) 22 (33)
N2 23 (9) 21 (16) 7 (11) 0.148
TNM stage
I 63 (24) 10 (8) 4 (6)
II 102 (39) 68 (52) 33 (50)
III 94 (37) 52 (40) 29 (44) 0.001
Haemoglobin
X12g per 100ml 180 (70) 64 (49) 11 (17)
o12g per 100ml 79 (30) 66 (51) 55 (83) o0.001
White cell count
o8.5 10
9/l 191 (74) 63 (49) 26 (39)
8.5–11.0 10
9/l 52 (20) 42 (32) 24 (37)
411 10
9/l 16 (6) 25 (19) 16 (24) o0.001
Complications
None 223 (86) 105 (81) 41 (62)
Infectious 25 (10) 21 (16) 24 (36)
Non-infectious 11 (4) 4 (3) 1 (2) 0.004
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spatients (n¼455) who underwent curative surgery for colorectal
cancer is shown in Table 1. The majority of patients were over the
age of 65 years (70%), were male (58%), were deprived (53%), and
presented for elective surgery (85%). The majority of patients
presented with colonic tumours (60%) had T3–4 disease (81%), no
nodal involvement (61%) and had TNM stage I/II disease (61%).
The majority of patients had preoperative haemoglobin (56%),
white cell count (87%) and mGPS 0 (58%) in the normal range.
After surgery, 86 (19%) patients developed a postoperative
complication; 70 (81%) of which were infectious complications.
The 16 non-infectious events were pulmonary embolism (n¼1),
myocardial infarction (n¼6), acute coronary syndrome (n¼5) and
acute onset atrial fibrillation (n¼4). The 70 infectious events were
septicaemia (n¼6), pneumonia (n¼33), anastomotic leak (n¼14),
intra-abdominal collection (n¼2) and wound infection (n¼15).
An elevated mGPS was associated with deprivation (Po0.05),
emergency presentation (Po0.001), peritoneal soiling (Pp0.01)
colonic tumours (Po0.001), advanced tumour stage (Po0.01), low
haemoglobin (Po0.001), high white cell count (Po0.001) and
postoperative infections (Po0.01).
The relationship between clinicopathological characteristics,
systemic inflammatory response and postoperative infections
in patients undergoing surgery for colorectal cancer is shown in
Table 2. On binary logistic regression analysis, deprivation
(Po0.10), emergency presentation (Po0.001), peritoneal soiling
(P¼0.001), elevated preoperative white cell count (Po0.001),
C-reactive protein (Po0.001), albumin (Po0.001) and mGPS
(o0.001) were associated with increased risk of developing a
postoperative infection. On multivariate analysis, peritoneal
soiling (Po0.01), elevated preoperative white cell count
(Po0.05) and mGPS (Po0.01) were independently associated
with increased risk of developing a postoperative infection.
When only those patients who presented electively were consi-
dered in the analysis (n¼385), on binary logistic regression
analysis, only the mGPS (OR¼1.75, 95% CI¼1.17–2.63,
P¼0.007) was significantly associated with increased risk of
developing a postoperative infection.
DISCUSSION
The results of this study show that the preoperative systemic
inflammatory response, as evidenced by the mGPS, was indepen-
dently associated with an increased risk of postoperative infectious
complications in patients undergoing potentially curative resection
for colorectal cancer. This relationship persisted after patients
with an emergency presentation were excluded from the logistic
regression analysis. Given that postoperative infections are relatively
common in patients undergoing surgery for colorectal cancer and
are associated with increased hospital stay and treatment costs, it
may be that the simple routinely available preoperative measure-
ment of the mGPS will be clinically useful in identifying patients at
high risk of developing infectious complications.
The basis of the independent relationship between an elevated
mGPS before surgery and postoperative infections in patients with
primary operable colorectal cancer is not clear. A plausible
explanation is that an elevated mGPS may reflect compromised
cell-mediated immunity as C-reactive protein is associated with
lymphopenia (Nozoe et al, 2000; Leitch et al, 2007) and an
impaired T-lymphocytic response (Canna et al, 2005) in patients
with colorectal tumours. Alternatively, C-reactive protein is also
associated with components of the innate immune system,
including complement, and this response may also be compro-
mised (Du Clos and Mold, 2004; Ytting et al, 2006). Also, an
mGPS of 2, based as it is on the presence of an ongoing systemic
inflammatory response and hypoalbuminaemia, reflects the loss of
lean tissue and protein (McMillan et al, 1998; McMillan et al,
2001), which is likely to further compromise immune function.
Therefore, the results of this study suggest that compromised
immune function may occur before surgery and influences
postoperative infectious complications.
It was of interest that, in this study, an elevated preoperative white
cell count was also independently associated with increased risk of
postoperative infectious complications. However, the white cell count
was strongly associated with mGPS, and compared with the mGPS,
the significance of its association weakened on multivariate analysis.
Furthermore, in those patients who presented electively, white cell
count was no longer significantly associated with postoperative
infection. This would support the routine use of the mGPS to identify
patients at increased risk of developing infectious complications.
However, it remains to be determined whether the preoperative
systemic inflammatory response may be moderated and whether
such moderation may reduce postoperative infectious complications.
In summary, the results of this study indicate that a simple
inflammation-based prognostic score identifies patients at in-
creased risk of developing infectious complications following
potentially curative resection for colorectal cancer.
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Table 2 The relationship between the studied variables and postoperative infection in patients undergoing potentially curative surgery for colorectal
cancer (n¼455).
Univariate odds
ratio (95% CI) P-value
Multivariate odds
ratio (95% CI) P-value
Age (o65/65–74/X75 years) 1.01 (0.74–1.38) 0.961
Sex (female/male) 1.26 (0.74–2.12) 0.395
Deprivation (1–2/3–5/6–7) 1.51 (0.94–2.42) 0.089 0.335
Presentation (elective/emergency) 3.52 (1.96–6.32) o0.001 0.058
Peritoneal soiling (none or serous fluid/local pus/free pus or faeces) 7.17 (2.35–21.86) 0.001 4.91 (1.60–15.08) 0.005
Tumour site (colon/rectum) 1.02 (0.61–1.72) 0.935
Tumour (T1/T2/T3/T4) 1.19 (0.86–1.64) 0.295
Nodal involvement (N0/N1/N2) 0.99 (0.68–1.43) 0.942
TNM stage (I/II/III) 0.97 (0.68–1.38) 0.844
Haemoglobin (X12/o12g per 100mll) 1.53 (0.92–2.55) 0.104
White cell count (o8.0/8.5–11.0/411 10
9/l) 1.95 (1.41–2.72) o0.001 1.46 (1.01–2.11) 0.043
C-reactive protein (p10/410mgl
 1) 2.79 (1.64–4.74) o0.001
Albumin (X35/o35gl
 1) 3.14 (1.80–5.48) o0.001
mGPS (0/1/2) 2.28 (1.64–3.16) o0.001 1.76 (1.22–2.55) 0.003
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